TheraRadar
Clinical-Stage Companies / Laboratorios Silanes S.A. de C.V.

Laboratorios Silanes S.A. de C.V.

Pre-Approval PRO BETA
33
Total Trials
16
Phase 3
4
Phase 2
4
Recruiting
316
Score

Pipeline by Phase

Phase 3
16
Phase 2
4
Phase 1
13

Therapeutic Focus

Healthy Type 2 Diabetes Acute Low-back Pain Acute Low Back Pain Severe Acute Respiratory Syndrome Coronavirus 2

Clinical Trials (33)

NCT06916884 Phase 3 RECRUITING

Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine

Started: 11/11/2024

NCT06863636 Phase 3 RECRUITING

Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation

Started: 9/9/2024

NCT06863701 Phase 3 RECRUITING

Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis

Started: 1/27/2025

NCT06531707 Phase 3 RECRUITING

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

Started: 5/20/2024

NCT06863662 Phase 3 COMPLETED

Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm

Started: 9/18/2024

NCT07328022 Phase 3 COMPLETED

Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis

Started: 5/14/2025

NCT04841096 Phase 3 COMPLETED

Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure

Started: 3/21/2023

NCT06516094 Phase 3 COMPLETED

Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain

Started: 4/11/2024

NCT04927299 Phase 3 COMPLETED

Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

Started: 6/30/2022

NCT06517823 Phase 3 COMPLETED

Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain

Started: 4/26/2024

NCT05001555 Phase 3 COMPLETED

Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II

Started: 11/23/2021

NCT05324059 Phase 3 COMPLETED

Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic Origin

Started: 7/11/2022

NCT04968158 Phase 3 COMPLETED

Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain

Started: 11/29/2021

NCT04943692 Phase 3 SUSPENDED

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes

Started: 8/1/2021

NCT01386671 Phase 3 COMPLETED

Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes

Started: 6/1/2014

NCT04625985 Phase 2 COMPLETED

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.

Started: 7/14/2020

NCT04626089 Phase 2 WITHDRAWN

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2

Started: 2/1/2021

NCT00940472 Phase 2 COMPLETED

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients

Started: 3/1/2009

NCT00940797 Phase 2 COMPLETED

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

Started: 7/1/2008

NCT07454369 Phase 1 COMPLETED

Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination

Started: 10/24/2022

NCT07444164 Phase 1 COMPLETED

Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.

Started: 1/13/2025

NCT05389150 Phase 1 COMPLETED

Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects

Started: 1/17/2019

NCT05533073 Phase 1 COMPLETED

Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination

Started: 8/3/2020

NCT05428293 Phase 1 COMPLETED

Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen Oral Suspension

Started: 2/22/2019

NCT05428306 Phase 1 COMPLETED

Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination

Started: 10/23/2018

NCT04848714 Phase 1 COMPLETED

Pharmacokinetic Study Protocol of ANAWIDOW Lyophilized Powder for Solution for Intravenous Use in Fasting Conditions

Started: 7/1/2021

NCT05090449 Phase 1 COMPLETED

Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions

Started: 5/1/2019

NCT05027126 Phase 1 COMPLETED

Comparison of Bioavailability of Dexketoprofen-Vit B vs Dexketoprofen, in Healthy Subjects, Under Fasting Conditions

Started: 2/28/2019

NCT04895059 Phase 1 COMPLETED

Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

Started: 4/30/2017

NCT01437813 Phase 1 COMPLETED

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study

Started: 1/1/2011

NCT01437800 Phase 1 COMPLETED

BIOAVAILABILITY OF GLI/METXR (4/850 mg)

Started: 1/1/2011

NCT01560481 Phase 1 COMPLETED

Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers

Started: 12/1/2011

NCT00941161 Phase 4 COMPLETED

Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

Started: 2/1/2009

Drug Candidates

A1: Etoricoxib / Betamethasone in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.) A2: Etoricoxib (Arcoxia®, Laboratorios Schering-Plough, S.A. de C.V.) A3: Betamethasone (Celestone® Pediatric, Laboratorios Schering-Plough, S.A. de C.V.) A1: Ticagrelor / Acetylsalicylic acid in fixed dose combination capsule. (Laboratorios Silanes S.A. de C.V.) A2: Ticagrelor (BRILINTA®, AstraZeneca S.A. de C.V.) A3: Acetylsalicylic Acid (ASPIRINA JUNIOR®, Bayer de México S.A. de C.V.) Etoricoxib + Tizanidine fixed dose Etoricoxib fixed dose Fixed Dose Etoricoxib + Betamethasone Monotherapy Etoricoxib A1=Glimepiride / Vildagliptin / Metformin (1 mg/ 50 mg/ 500 mg)
Activity Status: Active
Last Trial Started: 5/14/2025
Last Trial Ended: 12/1/2025
Trials (12 months): 1
Completed Trials: 27
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.